Tympanostomy surgery performed under general anesthesia is the most common pediatric procedure in the U.S. with 1.2 million children annually. (1,2)

 

THE HUMMINGBIRD TTS:

Allows the option to use moderate sedation, for routine tympanostomy procedures in children

  • Under the guidance of your hospital anesthesiology/sedation team

Cost and location efficiencies

  • There is a financial incentive for all stakeholders to have options in and out of the operating room
  • Optional lower-cost (non-sterile) locations for moderate sedation procedures like sedation or procedure units

Satisfied parents

  • Child/family-friendly
  • Potential for faster recovery and reduced emergence delirium using moderate sedation
  • Parent/patient satisfaction measures connected to reimbursement (through ACO)

FEATURES:

  • Reduced trauma – One-Pass™ technology
  • Manual operation to maximize surgeon tactile feel
  • Vis-Tab™ for clear visualization and depth of penetration
  • Precision myringotomy – the right size, every time
pm_Ad_hugs_free.jpg

Potentially easy wake-ups — happy parents.

 
fpo.jpg

RESOURCES
entnet.org (American Academy of Otolaryngology – Head and Neck Surgery)
smarttots.org (International Anesthesia Research Society
pedsedation.org (Society for Pediatric Sedation)
aap.org (American Academy of Pediatrics - Guidelines for Treating Ear Infections)

2017 Preceptis Product Brochure — Download Brochure

A MILLION WAYS THEY WILL FIND YOU.

– HUMMINGBIRD TTS SOCIAL MEDIA CAMPAIGN – 

 
 

Combined Otolaryngology Society Meeting (COSM) 2016: 

Panel Session Content: Neurocognitive Effects of General Anesthesia in Children: Research, Rumors, and Real Parental Concerns: 

  • Know that families will be “shopping” for institutions and physicians that are modulating their approach when possible. 

  • Know the potential short-term and long-term outcomes. Convey the most common surgeries performed in children under age 5 and the groups at highest risk for peri-operative complications. 

  • Know that we do not have all the answers, medications or technologies to guarantee that no child will be susceptible to short-term or long-term neurocognitive outcomes. 

REFERENCES

    1. Strategic Health Resources, 2011 Preceptis Analysis, data on file, private payer national average
    2. Truven Health Analytics, Tympanostomy Outpatient View and Five Year Forecast, 2015 Health